Ljósmæðrablaðið - 31.12.1979, Blaðsíða 41

LJÓSMÆÐRABLAÐIÐ
153
TAFLA 1.
Overproduction
Undersecretion
Mixed
A. Fetal-maternal blood
group incompatibility —
Th. ABO, others
B. Hereditary spherocytosis
C. Nonspherocytic hemolytic
anemias
1. G6PD defieiency &
drug
2. Pyruvate kinase defic
3. Other erythrocyte en-
cyme defic.
4. a-Thalassemia
5. y-Thalassemia
6. Vitamin K3-induced
hemolysis
D. Extravascular blood —
petechiae, hematomata,
pulmonary, cerebral or
occult hemmorrhage
E. Polycythemia
1. Maternal-fetal or feto-
fetal transfusion
2. Delayed clamping of
ffie umbilical cord
F. Increased enterohepatic
circulation
1. Pyloric stenosis
2. Intestinal atresia or
sten osis including
annular pancreas.
3. Hirschsprung’s disease
4. Meconium ileus or
meconium plug
syndrome
5. Fasting and/or other
cause for hypoperi-
stals is
6. Drug-induced paralytic
ileus (hexamethon-
iums)
7. Swallowed blood.
Metabolic-endocrine
1. Familial nonhemolytic
jaundice, types 1 and 2
2. Galactosemia
3. Hypothyroidism
4. Tyrosinosis
5. Hypermethioninemia
6. Drugs and hormones
a. Novobiocin
b. Pregnanediol
c. Certain breast milks
d. Lucey-Driscoll
syndrome
7. Infants of diabetic
mothers
8. Prematurity
9. Hypopituitarism &
anencephaly
10. Cardiac failure
Obstructive
1. Biliary atresia
a. Trisomy 18
2. Choledochal cyst
3. Cystic fibrosis
4. Tumororband
(extrinsic obstruction)
5 Cholestatic syndromes
a. Progressive. elevated
serum bile acids
b. Non progressive,
normal serum bile
aciras
c. Intermittent
I. Sepsis
J. Intrauterine infections
1. Toxoplasmosis
2. Rubella
3. Cytomegalic inclusion-
body diasease
4. Herpes simplex
5. Syphilis
6. Hepatitis (HAA)
K. Epidemic hepatitis.
2. Ljósameðferð.
Ljósameðferó skal beita ef bilirubin fer fram úr 12 mg%.
Hætta skal ljósameðferð er bilirubin í serum fer undir 11
mg% og helst stöðugt eða lækkar án meðferðar. (Hér er
einungis átt við fullburða börn, en ekki fyrirbura).
Bilirubin absorberar mest ljós á bylgjulengd 450—460 nm
(nanometer).